Biomedical Biotechnology Research Unit (BioBRU), Department of Biochemistry and Microbiology, Rhodes University, Grahamstown, 6140, South Africa.
Sci Rep. 2017 Dec 15;7(1):17617. doi: 10.1038/s41598-017-18061-y.
Fibronectin is an extracellular matrix glycoprotein with key roles in cell adhesion and migration. Hsp90 binds directly to fibronectin and Hsp90 depletion regulates fibronectin matrix stability. Where inhibition of Hsp90 with a C-terminal inhibitor, novobiocin, reduced the fibronectin matrix, treatment with an N-terminal inhibitor, geldanamycin, increased fibronectin levels. Geldanamycin treatment induced a stress response and a strong dose and time dependent increase in fibronectin mRNA via activation of the fibronectin promoter. Three putative heat shock elements (HSEs) were identified in the fibronectin promoter. Loss of two of these HSEs reduced both basal and geldanamycin-induced promoter activity, as did inhibition of the stress-responsive transcription factor HSF1. Binding of HSF1 to one of the putative HSE was confirmed by ChIP under basal conditions, and occupancy shown to increase with geldanamycin treatment. These data support the hypothesis that fibronectin is stress-responsive and a functional HSF1 target gene. COLA42 and LAMB3 mRNA levels were also increased with geldanamycin indicating that regulation of extracellular matrix (ECM) genes by HSF1 may be a wider phenomenon. Taken together, these data have implications for our understanding of ECM dynamics in stress-related diseases in which HSF1 is activated, and where the clinical application of N-terminal Hsp90 inhibitors is intended.
纤连蛋白是细胞外基质糖蛋白,在细胞黏附和迁移中起关键作用。Hsp90 与纤连蛋白直接结合,Hsp90 的耗竭调节纤连蛋白基质的稳定性。用 C 端抑制剂诺维苯酮抑制 Hsp90 减少纤连蛋白基质,而用 N 端抑制剂格尔德霉素处理则增加纤连蛋白水平。格尔德霉素处理诱导应激反应,并通过激活纤连蛋白启动子,强烈地剂量和时间依赖地增加纤连蛋白 mRNA。在纤连蛋白启动子中鉴定出三个潜在的热休克元件(HSE)。这两个 HSE 的缺失减少了基础和格尔德霉素诱导的启动子活性,应激反应转录因子 HSF1 的抑制也是如此。在基础条件下通过 ChIP 证实了 HSF1 与一个假定的 HSE 结合,并且随着格尔德霉素处理,占有率增加。这些数据支持这样一种假设,即纤连蛋白是应激反应的,是 HSF1 的功能靶基因。COL42 和 LAMB3 mRNA 水平也随格尔德霉素增加,表明 HSF1 对细胞外基质(ECM)基因的调节可能是一种更广泛的现象。总之,这些数据对我们理解 HSF1 激活的应激相关疾病中 ECM 动力学具有重要意义,并且打算将 N 端 Hsp90 抑制剂应用于临床。